文献速递肝胆胰外科围术期管理与 ERAS

远端胰腺切除术后胰瘘风险评分(D-FRS):开发与国际验证

Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation.
PubMed 文献 · Ann Surg · 2022-07-07

本研究基于意大利两中心2014-2016年远端胰腺切除(DP)患者数据,用多变量逻辑回归开发术前和术中两个胰瘘(POPF)风险评分,并与美国及荷兰五中心2007-2016年数据合并进行内外部验证。共纳入1336例患者,291例(22%)发生POPF。术前评分包含胰颈厚度和胰管直径,内部验证AUC为0.83(95%CI 0.78-0.88),内外部验证AUC为0.73(95%CI 0.70-0.76);术中评分增加BMI、胰腺质地和手术时间,AUC为0.80(95%CI 0.74-0.85)。

要点

  • 术前D-FRS仅含胰颈厚度和胰管直径两个变量,可用于术前风险分层。
  • 术中D-FRS增加BMI、胰腺质地和手术时间,可在术毕评估胰瘘风险。
  • 评分将患者分为低危(<10%)、中危(10%-25%)和高危(>25%)三组。

核心结论

  • 术前和术中D-FRS是首个经国际验证的远端胰腺切除术后胰瘘风险评分,有助于个体化治疗和基准比较。

研究设计与样本

  • 使用意大利两中心2014-2016年DP患者数据,通过多变量逻辑回归开发两个预测评分,并用bootstrapping进行内部验证;再与美国和荷兰五中心2007-2016年数据合并进行内外部验证。
  • 总样本1336例,其中291例(22%)发生POPF。

主要发现

  • 术前D-FRS包含胰颈厚度(每增加1mm,OR 1.14;95%CI 1.11-1.17)和胰管直径(每增加1mm,OR 1.46;95%CI 1.32-1.65)。
  • 术前D-FRS内部验证AUC为0.83(95%CI 0.78-0.88),内外部验证AUC为0.73(95%CI 0.70-0.76)。
  • 低危(<10%)、中危(10%-25%)、高危(>25%)组分别有238例(18%)、684例(51%)、414例(31%)。
  • 术中D-FRS增加BMI、胰腺质地和手术时间,AUC为0.80(95%CI 0.74-0.85)。

关键数值与推荐

  • 术前D-FRS计算时机为手术前,旨在促进预防策略;术中D-FRS计算时机为手术结束时,旨在促进减轻策略。
  • 风险分组阈值:低危<10%,中危10%-25%,高危>25%。

临床怎么用

  • 术前D-FRS可用于识别高危患者并制定预防性策略;术中D-FRS可在术毕评估风险以指导术后管理和减轻措施。
  • 评分工具可在http://www.pancreascalculator.com获取。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop 2 distinct preoperative and intraoperative risk scores to predict postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP) to improve preventive and mitigation strategies, respectively. BACKGROUND: POPF remains the most common complication after DP. Despite several known risk factors, an adequate risk model has not been developed yet. METHODS: Two prediction risk scores were designed using data of patients undergoing DP in 2 Italian centers (2014-2016) utilizing multivariable logistic regression. The preoperative score (calculated before surgery) aims to facilitate preventive strategies and the intraoperative score (calculated at the end of surgery) aims to facilitate mitigation strategies. Internal validation was achieved using bootstrapping. These data were pooled with data from 5 centers from the United States and the Netherlands (2007-2016) to assess discrimination and calibration in an internal-external validation procedure. RESULTS: Overall, 1336 patients after DP were included, of whom 291 (22%) developed POPF. The preoperative distal fistula risk score (preoperative D-FRS) included 2 variables: pancreatic neck thickness [odds ratio: 1.14; 95% confidence interval (CI): 1.11-1.17 per mm increase] and pancreatic duct diameter (OR: 1.46; 95% CI: 1.32-1.65 per mm increase). The model performed well with an area under the receiver operating characteristic curve of 0.83 (95% CI: 0.78-0.88) and 0.73 (95% CI: 0.70-0.76) upon internal-external validation. Three risk groups were identified: low risk (<10%), intermediate risk (10%-25%), and high risk (>25%) for POPF with 238 (18%), 684 (51%), and 414 (31%) patients, respectively. The intraoperative risk score (intraoperative D-FRS) added body mass index, pancreatic texture, and operative time as variables with an area under the receiver operating characteristic curve of 0.80 (95% CI: 0.74-0.85). CONCLUSIONS: The preoperative and the intraoperative D-FRS are the first validated risk scores for POPF after DP and are readily available at: http://www.pancreascalculator.com . The 3 distinct risk groups allow for personalized treatment and benchmarking.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. De Pastena M, van Bodegraven EA, Mungroop TH, et al. Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation. Ann Surg. 2022. PMID: 35797608. doi:10.1097/SLA.0000000000005497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。